en_US EN
en_US EN fr_FR FR
Login to LiveSLR
Login to MyCytel
Solutions
Drug Development Cycle
Discovery
Phase I-III Clinical Trials
Commercialization
Real-World Evidence Solutions
Strategic Data Science and Analytical Methods
Clinical Trial Design
Trial Delivery
Advanced Analytics
Specialty Areas
Discovery

Our innovative preclinical solutions empower your drug development journey with cutting-edge analytics and insights from inception to preclinical stages.

Find out more
Phase I-III Clinical Trials

We help you navigate complex trial phases efficiently with data-driven methods & strategies tailored to Phase I-III trials for accelerated drug development.

Learn more
Commercialization

Maximize your market potential and optimize your commercial strategies with our advanced analytical methods, data science, and tailored commercialization solutions for data-driven commercial success.

Learn more
Real-World Evidence Solutions

Harness the power of real-world data and real-world evidence to gather insights and shape future drug development cycles for enhanced efficacy and regulatory compliance.

Find out more
Clinical Trial Design

Craft optimal trial designs with our advanced analytical methods to enhance efficiency and increase the probability of success throughout your drug’s lifecycle.

Learn more
Trial Delivery

Empower your trial delivery by transforming trial designs into actionable strategies with our data-driven approach to ensure seamless delivery and successful outcomes.

Find out more
Advanced Analytics

Unlock the power of data with our methods for actionable insights to drive informed decisions and optimize clinical trial outcomes.

Learn more
Specialty Areas

We offer tailored analytics solutions for your specialized or niche projects enabling you to optimize both efficiency and precision in drug development.

Learn more
Quick Links
Data Strategy Model-lnformed Drug Development Chemistry, Manufacturing and Controls (CMC) Toxicology Solutions Clinical Pharmacology, Drug Metabolism and Pharmacokinetics
Adaptive Trial Designs Complex and Innovative Trial Design Model-lnformed Drug Development Clinical Development Strategy and Planning End-to-End Biometrics Axio® Data Monitoring Committee Data Strategy Regulatory Strategy Market Access Real-World Evidence Software for Trial Design
Health Economics and Outcomes Research (HEOR) Market Access Regulatory Strategy Real-World Evidence Health and Technology Assessments stève consultants
Real-World Evidence Real-World Data Real-World Data Software Post-Authorization Safety Studies stève consultants
Adaptive Trial Design Complex and Innovative Trial design Model-lnformed Drug Development Software for Trial Design
End-to-End Biometrics Data Management Early Phase Solutions Late Phase Solutions Axio® Data Monitoring Committee Safety & Regulatory Compliance FSP Outsourcing Outsourcing per Project Software for Trial Implementation
Systematic Literature Reviews Complex and Innovative Trial Design Market Access Health Economics & Outcomes Research Real-World Evidence Real-World Data Health and Technology Assessments
Synthetic Controls External Controls Rare Diseases Oncology Post-Authorization Safety Studies Decentralized Trials Pediatrics
Delivery Models
Strategic Consulting
Beyond Functional Service Provider
Project-Based Analytical Solutions
Software Solutions
Trial Design Software
Trial Implementation and Decision Support Software
LiveSLR® Software for Systematic Literature Reviews
Strategic Consulting

Enhance your clinical trial design with our strategic consulting services, featuring adaptive trial models and comprehensive regulatory guidance to ensure innovative, compliant, and successful trial outcomes.

Learn more
Beyond Functional Service Provider

Experience the future of flexible strategic partnerships with Analytics on Demand, providing adaptive and innovative solutions that transcend traditional models to achieve unparalleled operational excellence.

Learn more
Project-Based Analytical Solutions

Maximize efficiency and outcomes with our project-based services, delivering specialized expertise, end-to-end biometrics, and focused solutions for unique projects, ensuring timely completion and exceptional results.

Project-Based Analytical Solutions
Trial Design Software

Cytel's software platform enables precise trial design and simulation, utilizing adaptive and Bayesian tools to optimize protocols and accelerate drug development with confidence and efficiency.

Learn more
Trial Implementation and Decision Support Software

Our unique software package streamlines trial implementation with intuitive solutions for protocol development, randomization, and patient management, optimizing operational efficiency and ensuring study success.

Learn more
LiveSLR® Software for Systematic Literature Reviews

Learn more
Quick Links
Adaptive Trial Designs Advanced Analytics Regulatory Strategy Clinical Development Strategy & Planning Discovery and Pre-clinical Clinical Pharmacology, drug metabolism and pharmacokinetics
Staff Augmentation Strategic Capacity Management Functional Service Provider Hybrid FSP Model
Data Management End-to-End Biometrics Data Submission support Axio® Data Monitoring Committee Medical Writing
East Horizon™ Platform for Trial Design Xact software suite, StatXact®
Enforesys
About Us
About Us

Learn about our rich history, visionary leadership, and core values. Our mission and vision drive us to deliver excellence in drug development globally.

Learn more
Quick Links
Our Experts Leadership Team Innovation Advisory Board
 
Board of Directors Sustainability
Insights
Insights

Explore Cytel’s Insights hub - your source for the latest news, event updates, and expert insights on advanced data analytics and data science.

Explore now
Quick Links
Perspectives News and Events Resource Library Publications
 
Careers
Careers

Join our innovative team at Cytel! Explore exciting career opportunities in data science and statistics, analytical methods, and regulatory strategy. Advance the future of human health with us.

Learn more
Quick Links
Connect with Us Join our Talent Network Find our Latest Opportunities
 
Contact Us
en_US EN
en_US EN fr_FR FR
Contact us
Contact Us
Customer Support
Customer Support
en_US EN
en_US EN fr_FR FR
Login to LiveSLR
Login to MyCytel
Contact us
Contact Us
Customer Support
Customer Support

Perspectives

Unlock new insights with Cytel’s Perspectives blog. Our experts share their views on the latest industry trends, with cutting-edge thought leadership and expert analyses spanning the spectrum of drug development and clinical trials. 

Home
Search
Perspectives

Filters

Reset All filters
search-filter

By Topic
arrow-bottom

Synthetic Controls
Subpopulation
Submission
Strategic Consulting
Statistical Programming
Software
SLR
Regulatory Affairs
Real-World Evidence
Real-World Data
Rare Diseases
Platform Trials
Phase 3
Phase 2
Phase 1
Pediatrics
PBS
Open Source
Oncology
Master Protocol
Market Access
ISPOR
Inflation Reduction Act
Industry Voices
HTA
HEOR
Group Sequential Designs
FSP
FDA
External Control Arms
EVA
East Horizon
East
Early Phase
Data Strategy
Data Monitoring Committees
Data Management
Cytel Sweden
Comparative Effectiveness
CoFaktor
CNS
CMC
Clinical Trial Design
Clinical Pharmacology
Clinical Development Strategy
CDISC
Careers
Biometrics
Bayesian Methods
Basket Trials
Axio
Artificial Intelligence and Machine Learning
Adaptive Clinical Trials

By Year
arrow-bottom

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2011
2010
2009
2008
2007
2006

By Author
arrow-bottom

Abbey Poirier
Abhishek Ghalsasi
Abhishek Joshi
Adrian Martins
Alexander Schacht
Alind Gupta
Amruta Radhakrishnan
Angela Vinken
Angelo Tinazzi
Angie Raad-Faherty
Anita Chudecka
Ann-Kristin Spiik
Anne-Sophie Le Bescond
Åsa Holmgren
Bart Heeg
Bastian Gaus
Becky Gatesman
Benjamin Piske
Bill Coar
Boaz Adler
Cedric Marchand
Corey Dunham
Cyrus Mehta
Cytel
David Dahlgren
David Kerr
Delphine Issard
Dr Yuan Ji
Dr. Sharayu More-Deshmukh
Elizabeth Vinand
Elsa Lilienberg
Emily Woolley
Erika Daly
Erika Spens
Eswara Gunisetti
Evie Merinopoulou
Fei Tang
Florence Le Maulf
Françoise Bugnard
Goullou Keita
Gowri Sivakumar Ambalavanan
Grammati Sarri
Haripria Ramesh Babu
Heather Jones
Heather Struntz
Helene Cauwel-Schryve
Holger Müller
Hoora Moradian
Ingrid Lönnstedt
James (Jim) Bolognese
James Matcham
Jason Simeone
Jasperlynn Kao
Jeffrey M. Muir
Jenn Sustin
Jennifer Lurie
Jessica Bhoyroo
Jonas Häggström
Jonathan Burr
Josselin Boussel
Jovan Willford
Juan Benavides
Juan Pablo Garcia Martinez
Julia Poritz
Kathryn Wright
Kevin Black
Kevin Trimm
Krishna Padmanabhan
Kunal Sanghavi
Kyle Wathen
Lilia Leisle
Loraine Monfort
Lucile Marié
Lydia Vinals, PhD
Malte Stein
Manish Deole
Mansha Sachdev
Manuel Cossio
Marco Ghiani
Maria Fernström
Maria Rizzo
Martin Kappler
Maud Perpere
Michael Fossler
Michael Groff
Michaela Šedová
Michelle Hoiseth
Mike Dolph
Natalia Mühlemann
Nathalie Horowicz-Mehler
Naydene Slabbert
Nelia Padilla
Nicolas Rouillé
Nitin Patel
Ophélie Calas-Zeroug
Pantelis Vlachos
Patti Arsenault
Peggy Schrammel
Peter Wigfield
Philipp Bauknecht
Ralf Koelbach
Reza Jafar
Robert Szulkin
Romain Moreau
Russanthy Velummailum
Sadiqa Mahmood
Scott Rogers
Sebastià Barceló
Shanna Cotti
Sheree King
Sofie Vandevyver
Sophie van Beekhuizen
Stacy Grieve
Stefan Baumanns
Stéphanie Dontenville
Stephanie Rondeau
Stève Bénard
Steven Thacker
Strategic Consulting
Subhajit Sengupta
Susannah Sadler
Valeria Mazzanti
Veena Palle
Vicki Young
Victor Laliman-Khara
Walter Boyle
Walter Briggs
William Baker
Wyatt Gotbetter
December 18, 2025
2025 in Perspective: Reflections From Our Newest Colleagues
Cytel
Read More
December 16, 2025
Beyond the Database: How Clinical Data Management Transforms Patient Care
Naydene Slabbert
Read More
December 11, 2025
The Medical AI Superintelligence Test and NOHARM: A New Framework for Assessing Clinical Safety in AI Systems
Manuel Cossio
Read More
December 9, 2025
FDA Guidance on Assessing Overall Survival in Oncology Trials: A DMC Perspective
David Kerr
David Kerr
Read More
December 4, 2025
Evaluating Safety and Efficacy in Phase III Alzheimer’s Disease Trial: Endpoints and Statistical Analysis Methods
Maud Perpere
Read More
December 2, 2025
Empowering Patient Engagement in HTA: Lessons from an AI-Generated Plain Language Summary Case Study
Manuel Cossio
Read More
November 25, 2025
Regulatory Guidance on Patient-Centric DMC Risk-Benefit Assessments
Becky Gatesman
 ,
Emily Woolley
Read More
November 18, 2025
The FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies
Michael Fossler
Michael Fossler
Read More
November 14, 2025
Career Perspectives: A Conversation with Ajay Sathe
Cytel
Read More
November 13, 2025
The Last “C” in CMC: Why Controls Are the Safeguard of Drug Development
Bengt Hedin, Senior Consultant at Cytel
Bengt Hedin
Read More
November 11, 2025
A Preview of Cytel’s Contributions at PHUSE EU 2025
Angelo Tinazzi
Read More
November 6, 2025
Statistical Insight for Strategic Impact: How Statisticians Help Medical Affairs Make the Most of Their Data
Goullou Keita
 ,
Delphine Issard
Read More